From January 1, 2023 to March 31, 2023, the company has repurchased 445,000 shares, representing 0.08% for CNY 2.65 million. With this, the company has completed the repurchase of 7,643,500 shares, representing 1.36% for CNY 40.3 million under the buyback announced on July 15, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
5.19 CNY | -1.52% | -0.57% | -15.33% |
1st Jan change | Capi. | |
---|---|---|
-15.33% | 408M | |
+31.37% | 588B | |
-2.56% | 364B | |
+20.79% | 326B | |
+5.89% | 285B | |
+14.83% | 239B | |
+9.93% | 210B | |
-6.95% | 200B | |
+11.17% | 167B | |
+0.07% | 161B |
- Stock Market
- Equities
- 600222 Stock
- News Henan Taloph Pharmaceutical Stock Co.,Ltd
- Tranche Update on Henan Taloph Pharmaceutical Stock Co.,Ltd's Equity Buyback Plan announced on July 15, 2022.